Future gazing with Hannah Kuchler
Three hot IP issues for the pharmaceutical industry
par Dr Paul England
Sale of Theramex by CVC to Carlyle and PAI Partners completes
par Emma Danks et Suzy Davis
Orphan drug protection: clarification needed
par Dr Paul England
UK medicines – Is the Northern Ireland Protocol now unsustainable?
par Dr Paul England
The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?
Available in English and Japanese
par Dr Paul England
English patent torpedoes and the UPC
par Dr Paul England
Advising Apollo Therapeutics on $145 million financing
par Andrew Edge et Chris Cowley
Compulsory licensing in Germany – the coronavirus crisis and beyond
Conférences et Webinars
Retrouvez les analyses de nos experts sur les dernières questions juridiques.
Voir tous les évènements
Future gazing with Hannah Kuchler
Three hot IP issues for the pharmaceutical industry
par Dr Paul England
Sale of Theramex by CVC to Carlyle and PAI Partners completes
par Emma Danks et Suzy Davis
Orphan drug protection: clarification needed
par Dr Paul England
UK medicines – Is the Northern Ireland Protocol now unsustainable?
par Dr Paul England
The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?
Available in English and Japanese
par Dr Paul England
English patent torpedoes and the UPC
par Dr Paul England
Advising Apollo Therapeutics on $145 million financing
par Andrew Edge et Chris Cowley
Compulsory licensing in Germany – the coronavirus crisis and beyond